EcoDrugPlus

Carbonic Anhydrase Xiv

Ensembl ID : ENSNFUG00015021788
Gene Symbol: CA14
1 Cross references
210 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSNFUG00015010874
Gene Symbol: CSNK1E
3 Cross references
211 Possible Orthologues:

Casein Kinase 1, Epsilon

Ensembl ID : ENSNFUG00015019240
Gene Symbol: CSNK1E
1 Cross references
196 Possible Orthologues:

Caspase 9, Apoptosis-Related Cysteine Peptidase

Ensembl ID : ENSNFUG00015009045
Gene Symbol: CASP9
1 Cross references
201 Possible Orthologues:

Caspase 9, Apoptosis-Related Cysteine Peptidase

Ensembl ID : ENSNFUG00015022582
Gene Symbol: CASP9
1 Cross references
201 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSNFUG00015013912
Gene Symbol: COMT
3 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSNFUG00015003458
Gene Symbol: CTSC
1 Cross references
237 Possible Orthologues:

Cathepsin K-Like

Ensembl ID : ENSNFUG00015019460
Gene Symbol: LOC107379225
3 Cross references
222 Possible Orthologues:

Cathepsin S-Like

Ensembl ID : ENSNFUG00015019454
Gene Symbol: LOC107379223
3 Cross references
233 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSNFUG00015019573
Gene Symbol: CDC7
3 Cross references
207 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSNFUG00015021096
Gene Symbol: CHEK2
1 Cross references
205 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSNFUG00015000941
Gene Symbol: CCKAR
3 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).